Srikanta Dash

Title: Srikanta Dash: Innovator in Flavivirus Research

Introduction

Srikanta Dash is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of virology, particularly in the development of peptides that inhibit Flavivirus infections. With a total of 3 patents, his work is pivotal in advancing therapeutic options for viral diseases.

Latest Patents

Srikanta Dash's latest patents focus on Flavivirus fusion inhibitors. The first patent provides an isolated peptide with an amino acid sequence selected from a specific group, along with derivatives that include various chemical moieties. These peptides are designed for treating and preventing Flavivirus infections. The second patent relates to methods of inhibiting the fusion between the virion envelope of Flaviviruses and the membranes of target cells. This process is crucial for delivering the viral genome into the cell cytoplasm. The invention is based on the discovery of previously undescribed structures of envelope glycoproteins in hepaciviruses and pestiviruses. His work offers new methods for the treatment and prophylaxis of diseases induced by Flaviviruses.

Career Highlights

Throughout his career, Srikanta Dash has worked with prestigious institutions, including the Administrators of the Tulane Educational Fund and The Rockefeller University. His research has significantly impacted the understanding and treatment of viral infections.

Collaborations

Srikanta has collaborated with notable colleagues such as Robert F Garry and David H Coy. Their combined expertise has furthered the research in Flavivirus and related fields.

Conclusion

Srikanta Dash's innovative work in Flavivirus research exemplifies the importance of scientific inquiry in developing effective treatments for viral infections. His contributions continue to influence the field and offer hope for future advancements.